Search
You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "pharmaceuticals."
12 result(s) displayed (25 - 36 of 44)
Cephalon Inc. now has the novel distinction of changing the fortunes of two different global pharmaceutical companies on the same day. Continue reading
Posted on October 18, 2011 2:44 PM
Roche's $230 million deal for the hepatitis C developer shows that Big Pharma may target smaller pharmaceutical companies to compete in the market. Continue reading
Posted on October 17, 2011 3:48 PM
An acquiring company should approach a government fraud probe into a potential target as just another factor to assess during the due diligence phase Continue reading
Posted on September 28, 2011 2:52 PM
With 16 Big Pharma partnerships worth more than $3.3 billion in potential milestones and royalty payments, Array BioPharma Inc. is poised to turn from a net loss clinical-stage biopharma to a revenue-growing drug seller.Those reasons could also make it an... Continue reading
Posted on September 20, 2011 9:28 AM
InterMune Inc. plans to seek about $200 million in a secondary offering to help its expected launch of a lung disease drug Continue reading
Posted on September 14, 2011 12:00 PM
Brandi Moore, founder of consulting firm India Think, chats with The Deal Pipeline about why foreign VCs are investing in India's burgeoning pharmaceutical market, and how Indian pharma groups are returning the favor. Continue reading
Posted on September 7, 2011 4:00 AM
Brandi Moore, founder of consulting firm India Think, chats with The Deal Pipeline about why foreign VCs are investing in India's burgeoning pharmaceutical market, and how Indian pharma groups are returning the favor. Continue reading
Posted on September 7, 2011 4:00 AM
Afexa Life Sciences Inc. has signed a deal to be acquired by Valeant Pharmaceuticals for $78 million. Continue reading
Posted on August 31, 2011 12:04 PM
French drugmaker Sanofi-Aventis SA has become the latest Big Pharma entity to strike in India, using subsidiary Aventis Pharma Ltd. to grab a division of Mumbai's Universal Medicare Private Ltd.Aventis Pharma, an India-based entity in which Sanofi owns a 60.4%... Continue reading
Posted on August 24, 2011 2:46 PM
Par Pharmaceutical Cos. said Wednesday, Aug. 24, that it will buy privately held rival Anchen Pharmaceuticals Inc. for $410 million in cash to extend its portfolio of generic products.The deal is part of a rush by generic drug manufacturers to... Continue reading
Posted on August 24, 2011 11:16 AM
M&A in the biotechnology and pharmaceutical industries is shaping up to rebound in 2011, a new report indicates, given momentum by deals such as the $20.1 billion biotech buyout of Genzyme Corp. by French pharmaceutical giant Sanofi-Aventis SA in February... Continue reading
Posted on August 16, 2011 4:31 PM
Movable Type search results powered by Fast Search
NBGI Private Equity appointed food and drinks industry veteran Tim Kelly as a senior adviser. For other updates launch today's Movers & shakers slideshow.
Blackstone Real Estate and DDR divide 46 shopping centers in a $1.46 billion deal. More video
